Abbott Laboratories (BIT:1ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	179,490	185,550	189,494	172,877	179,118	212,232
Market Cap Growth	-6.43%	-2.08%	9.61%	-3.48%	-15.60%	38.39%
Enterprise Value	184,237	190,279	196,729	180,897	185,558	220,076
Last Close Price	103.06	105.82	-	-	-	-
PE Ratio	32.30	33.39	14.69	33.52	27.72	34.28
PS Ratio	4.75	4.92	4.68	4.76	4.39	5.60
PB Ratio	4.11	4.25	4.10	4.92	5.19	6.70
P/TBV Ratio	9.85	10.19	10.96	31.28	55.76	-
P/FCF Ratio	-	-	30.89	37.77	24.53	27.91
P/OCF Ratio	-	-	22.92	26.32	19.98	22.92
EV/Sales Ratio	4.86	5.04	4.86	4.99	4.54	5.81
EV/EBITDA Ratio	19.32	20.03	19.01	19.11	16.02	19.64
EV/EBIT Ratio	26.76	27.74	27.17	27.69	21.76	27.19
EV/FCF Ratio	-	-	32.07	39.52	25.41	28.94
Debt / Equity Ratio	0.25	0.25	0.32	0.41	0.49	0.53
Debt / EBITDA Ratio	1.16	1.16	1.38	1.48	1.41	1.47
Debt / FCF Ratio	-	-	2.41	3.16	2.30	2.23
Asset Turnover	-	-	0.54	0.54	0.58	0.58
Inventory Turnover	-	-	2.92	2.81	3.37	3.56
Quick Ratio	-	-	1.05	1.00	1.06	1.28
Current Ratio	-	-	1.67	1.64	1.63	1.85
Return on Equity (ROE)	13.16%	13.16%	30.91%	15.11%	19.01%	20.49%
Return on Assets (ROA)	-	-	6.06%	6.11%	7.61%	7.79%
Return on Invested Capital (ROIC)	10.98%	11.11%	14.59%	13.45%	16.96%	17.46%
Return on Capital Employed (ROCE)	-	-	11.10%	12.20%	15.50%	14.80%
Earnings Yield	3.10%	3.00%	6.83%	3.00%	3.62%	2.93%
FCF Yield	-	-	3.24%	2.65%	4.08%	3.58%
Payout Ratio	-	-	28.62%	62.13%	47.73%	45.28%
Buyback Yield / Dilution	-0.06%	-0.06%	0.06%	0.85%	1.40%	-0.17%
Total Shareholder Return	2.03%	-0.06%	0.06%	0.85%	1.40%	-0.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.